Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
QuantRx Biomedical Corporation (QTXB)
OTHER OTC:QTXB
QuantRx Biomedical (QTXB) Stock Price & Analysis
2 Followers
QTXB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.01
Previous Close$0.01
Volume50.00K
Average Volume (3M)N/A
Market Cap
$314.79K
Enterprise Value$1.80M
Total Cash (Recent Filing)$3.88K
Total Debt (Recent Filing)$1.49M
Price to Earnings (P/E)―
Beta1734.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding78,696,461
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.69
R-Squared0.03
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-40.63
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
QTXB FAQ
What was QuantRx Biomedical Corporation’s price range in the past 12 months?
QuantRx Biomedical Corporation lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is QuantRx Biomedical Corporation’s market cap?
Currently, no data Available
When is QuantRx Biomedical Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were QuantRx Biomedical Corporation’s earnings last quarter?
Currently, no data Available
Is QuantRx Biomedical Corporation overvalued?
According to Wall Street analysts QuantRx Biomedical Corporation’s price is currently Overvalued.
Does QuantRx Biomedical Corporation pay dividends?
QuantRx Biomedical Corporation does not currently pay dividends.
What is QuantRx Biomedical Corporation’s EPS estimate?
QuantRx Biomedical Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QuantRx Biomedical Corporation have?
QuantRx Biomedical Corporation has 78,696,465 shares outstanding.
What happened to QuantRx Biomedical Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of QuantRx Biomedical Corporation?
Currently, no hedge funds are holding shares in QTXB
---
Company Description
QuantRx Biomedical Corporation
QuantRx Biomedical Corp. engages in the development and commercializing of patented miniform pads (PAD) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and medical needs. Its platforms include inSync(R), Unique(TM), PadKit(R), and original equipment manufacturer branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR.
---
Technical Analysis
Adaptimmune Therapeutics
―
Cellectar Biosciences
―
Fate Therapeutics
―
Cyclacel Pharmaceuticals
―
---